• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型主要蛋白酶(M)的温度依赖性构象集合

The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M).

作者信息

Ebrahim Ali, Riley Blake T, Kumaran Desigan, Andi Babak, Fuchs Martin R, McSweeney Sean, Keedy Daniel A

机构信息

Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, England, United Kingdom.

Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY 10031, USA.

出版信息

IUCrJ. 2022 Aug 17;9(Pt 5):682-694. doi: 10.1107/S2052252522007497. eCollection 2022 Sep 1.

DOI:10.1107/S2052252522007497
PMID:36071812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438506/
Abstract

The COVID-19 pandemic, instigated by the SARS-CoV-2 coronavirus, continues to plague the globe. The SARS-CoV-2 main protease, or M, is a promising target for the development of novel antiviral therapeutics. Previous X-ray crystal structures of M were obtained at cryogenic tem-per-ature or room tem-per-ature only. Here we report a series of high-resolution crystal structures of unliganded M across multiple tem-per-atures from cryogenic to physiological, and another at high humidity. We inter-rogate these data sets with parsimonious multiconformer models, multi-copy ensemble models, and isomorphous difference density maps. Our analysis reveals a perturbation-dependent conformational landscape for M, including a mobile zinc ion inter-leaved between the catalytic dyad, mercurial conformational heterogeneity at various sites including a key substrate-binding loop, and a far-reaching intra-molecular network bridging the active site and dimer inter-face. Our results may inspire new strategies for antiviral drug development to aid preparation for future coronavirus pandemics.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的新型冠状病毒肺炎(COVID-19)大流行继续困扰着全球。SARS-CoV-2主要蛋白酶(M)是开发新型抗病毒疗法的一个有前景的靶点。之前M的X射线晶体结构仅在低温或室温下获得。在此,我们报告了一系列未结合配体的M在从低温到生理温度的多个温度下以及在高湿度条件下的高分辨率晶体结构。我们用简约多构象模型、多拷贝集合模型和同晶型差异密度图来分析这些数据集。我们的分析揭示了M的一种依赖于扰动的构象态势,包括在催化二元体之间交错的一个移动锌离子、在包括一个关键底物结合环在内的各个位点的汞诱导构象异质性,以及一个连接活性位点和二聚体界面的广泛分子内网络。我们的结果可能会激发抗病毒药物开发的新策略,以帮助为未来的冠状病毒大流行做好准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/e32af80ab212/m-09-00682-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/b684328b4838/m-09-00682-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/4f7bdda1100b/m-09-00682-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/6b00ea570c64/m-09-00682-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/1bbb611ab4bd/m-09-00682-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/e32af80ab212/m-09-00682-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/b684328b4838/m-09-00682-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/4f7bdda1100b/m-09-00682-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/6b00ea570c64/m-09-00682-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/1bbb611ab4bd/m-09-00682-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b6f/9438506/e32af80ab212/m-09-00682-fig5.jpg

相似文献

1
The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M).严重急性呼吸综合征冠状病毒2型主要蛋白酶(M)的温度依赖性构象集合
IUCrJ. 2022 Aug 17;9(Pt 5):682-694. doi: 10.1107/S2052252522007497. eCollection 2022 Sep 1.
2
The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (M).严重急性呼吸综合征冠状病毒2型主要蛋白酶(M)的温度依赖性构象集合
bioRxiv. 2021 Nov 7:2021.05.03.437411. doi: 10.1101/2021.05.03.437411.
3
Genetic Surveillance of SARS-CoV-2 M Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid.SARS-CoV-2 M 基因监测显示,在引入蛋白酶抑制剂帕克洛维德之前,其序列和结构高度保守。
mBio. 2022 Aug 30;13(4):e0086922. doi: 10.1128/mbio.00869-22. Epub 2022 Jul 13.
4
Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.SARS-CoV-2 和 SARS 冠状病毒 3CL 蛋白酶的别构调节作用在晶体结构组合中观察到。
J Mol Biol. 2021 Dec 3;433(24):167324. doi: 10.1016/j.jmb.2021.167324. Epub 2021 Oct 27.
5
Optimization Rules for SARS-CoV-2 M Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.SARS-CoV-2 M 抗病毒药物的优化规则:冠状病毒蛋白酶活性位点的整体对接和探索。
Viruses. 2020 Aug 26;12(9):942. doi: 10.3390/v12090942.
6
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography.通过室温X射线晶体学可视化的新型冠状病毒主要蛋白酶的米氏样复合物
IUCrJ. 2021 Oct 5;8(Pt 6):973-979. doi: 10.1107/S2052252521010113. eCollection 2021 Nov 1.
7
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.蛋白质结构异质性:SARS-CoV 和 SARS-CoV-2 主要蛋白酶进行蛋白水解识别的基础假说。
Biochimie. 2021 Mar;182:177-184. doi: 10.1016/j.biochi.2021.01.010. Epub 2021 Jan 20.
8
Malleability of the SARS-CoV-2 3CL M Active-Site Cavity Facilitates Binding of Clinical Antivirals.SARS-CoV-2 3CL M 活性位点腔的可塑性促进了临床抗病毒药物的结合。
Structure. 2020 Dec 1;28(12):1313-1320.e3. doi: 10.1016/j.str.2020.10.007. Epub 2020 Oct 23.
9
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.肽醛抑制剂挑战了 SARS-CoV 主蛋白酶的底物特异性。
Antiviral Res. 2011 Nov;92(2):204-12. doi: 10.1016/j.antiviral.2011.08.001. Epub 2011 Aug 11.
10
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.

引用本文的文献

1
Dirhodium Tetraacetate Binding to Lysozyme at Body Temperature.体温下二醋酸二铑与溶菌酶的结合
Int J Mol Sci. 2025 Jul 9;26(14):6582. doi: 10.3390/ijms26146582.
2
Characterization of an unusual SARS-CoV-2 main protease natural variant exhibiting resistance to nirmatrelvir and ensitrelvir.一种对奈玛特韦和恩西特韦表现出抗性的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶天然变体的特征分析
Commun Biol. 2025 Jul 17;8(1):1061. doi: 10.1038/s42003-025-08487-w.
3
Probing the modulation of enzyme kinetics by multi-temperature, time-resolved serial crystallography.

本文引用的文献

1
Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease.丙型肝炎病毒 NS3/4A 抑制剂和其他类似药物化合物作为 SARS-CoV-2 主蛋白酶的共价结合物。
Sci Rep. 2022 Jul 16;12(1):12197. doi: 10.1038/s41598-022-15930-z.
2
Improving sampling of crystallographic disorder in ensemble refinement.提高整体精修中晶体无序的采样。
Acta Crystallogr D Struct Biol. 2021 Nov 1;77(Pt 11):1357-1364. doi: 10.1107/S2059798321010044. Epub 2021 Oct 20.
3
A method for intuitively extracting macromolecular dynamics from structural disorder.
通过多温度、时间分辨串行晶体学探究酶动力学的调制。
Nat Commun. 2025 Jul 16;16(1):6553. doi: 10.1038/s41467-025-61631-2.
4
Does crossing the pond affect crystal quality?跨越池塘会影响晶体质量吗?
bioRxiv. 2025 Jun 17:2025.06.12.659325. doi: 10.1101/2025.06.12.659325.
5
Structural biology at the National Synchrotron Light Source II.美国国家同步辐射光源II的结构生物学
J Synchrotron Radiat. 2025 Jul 1;32(Pt 4):873-883. doi: 10.1107/S1600577525003194. Epub 2025 Jun 26.
6
IUCrJ on passing its tenth anniversary and entering its second decade: progress, current status and prospects for the future.《IUCrJ》创刊十周年并迈入第二个十年之际:进展、现状与未来展望。
IUCrJ. 2025 Jan 1;12(Pt 1):1-3. doi: 10.1107/S205225252401217X.
7
Alpha-helices as alignment reporters in residual dipolar coupling analysis of proteins.α-螺旋作为蛋白质剩余偶极耦合分析中的比对报告基团。
J Biomol NMR. 2025 Mar;79(1):47-57. doi: 10.1007/s10858-024-00456-5. Epub 2024 Dec 11.
8
Mapping Protein Conformational Landscapes from Crystallographic Drug Fragment Screens.从晶体学药物片段筛选中绘制蛋白质构象景观图。
J Chem Inf Model. 2024 Dec 9;64(23):8937-8951. doi: 10.1021/acs.jcim.4c01380. Epub 2024 Nov 12.
9
Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy.人类蛋白酪氨酸磷酸酶1B(PTP1B)变体的结构揭示了可作为减肥疗法靶点的变构位点。
bioRxiv. 2025 Mar 8:2024.08.05.603709. doi: 10.1101/2024.08.05.603709.
10
Mapping protein conformational landscapes from crystallographic drug fragment screens.从晶体学药物片段筛选中绘制蛋白质构象图谱。
bioRxiv. 2024 Jul 30:2024.07.29.605395. doi: 10.1101/2024.07.29.605395.
一种直观提取结构无序中大分子动力学的方法。
Nat Commun. 2021 Sep 17;12(1):5493. doi: 10.1038/s41467-021-25814-x.
4
Zinc ion inhibits SARS-CoV-2 main protease and viral replication .锌离子抑制新型冠状病毒主要蛋白酶和病毒复制。
Chem Commun (Camb). 2021 Sep 30;57(78):10083-10086. doi: 10.1039/d1cc03563k.
5
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.SARS-CoV-2 主要蛋白酶成熟过程的晶体学快照。
J Mol Biol. 2021 Sep 3;433(18):167118. doi: 10.1016/j.jmb.2021.167118. Epub 2021 Jun 24.
6
Crystallographic models of SARS-CoV-2 3CL: in-depth assessment of structure quality and validation.严重急性呼吸综合征冠状病毒2 3CL的晶体学模型:结构质量的深入评估与验证
IUCrJ. 2021 Feb 9;8(Pt 2):238-256. doi: 10.1107/S2052252521001159. eCollection 2021 Mar 1.
7
FMX - the Frontier Microfocusing Macromolecular Crystallography Beamline at the National Synchrotron Light Source II.FMX - 国家同步辐射光源 II 上的前沿微聚焦大分子晶体学光束线。
J Synchrotron Radiat. 2021 Mar 1;28(Pt 2):650-665. doi: 10.1107/S1600577520016173. Epub 2021 Feb 25.
8
Small Glycols Discover Cryptic Pockets on Proteins for Fragment-Based Approaches.小分子甘醇可用于基于片段的方法探索蛋白质中的隐匿口袋。
J Chem Inf Model. 2021 Mar 22;61(3):1322-1333. doi: 10.1021/acs.jcim.0c01126. Epub 2021 Feb 11.
9
Macromolecular room temperature crystallography.大分子室温晶体学
Q Rev Biophys. 2021 Jan 8;54:e1. doi: 10.1017/S0033583520000128.
10
qFit 3: Protein and ligand multiconformer modeling for X-ray crystallographic and single-particle cryo-EM density maps.qFit 3:用于 X 射线晶体学和单颗粒冷冻电镜密度图的蛋白质和配体多构象建模。
Protein Sci. 2021 Jan;30(1):270-285. doi: 10.1002/pro.4001. Epub 2020 Nov 30.